title: [FDA phase II and phase III drug evaluation of antipsychotic agents].
authors.forename: K
authors.initials: K
authors.lastname: Yagi
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents